Sleep, death, and the heart

American Journal of Physiology - Heart and Circulatory Physiology

Volumn 309, Issue 5, 2015, Pages H739-H749

  Mansukhani, Meghna P ^a   Wang, Shihan ^b   Somers, Virend K ^b  

^a Affiliated Community Medical Centers   (United States)

^b MAYO CLINIC   (United States)

Author keywords

Arrhythmia; Cardiovascular; Mortality; Sleep apnea; Sleep disordered breathing

Indexed keywords

ATRIAL FIBRILLATION; BRUGADA SYNDROME; CARDIOVASCULAR DISEASE; CENTRAL SLEEP APNEA SYNDROME; CEREBROVASCULAR ACCIDENT; DEEP VEIN THROMBOSIS; DISEASE ASSOCIATION; EXERCISE TOLERANCE; HEART ARRHYTHMIA; HEART ATRIUM ARRHYTHMIA; HEART FAILURE; HEART INFARCTION; HEART MUSCLE ISCHEMIA; HEART VENTRICLE ARRHYTHMIA; HUMAN; HYPERTENSION; MORTALITY; PATENT FORAMEN OVALE; PATHOGENESIS; PERIODIC LIMB MOVEMENT DISORDER; POSITIVE END EXPIRATORY PRESSURE; PRIORITY JOURNAL; RESPIRATORY FAILURE; REVIEW; RISK FACTOR; SLEEP DEPRIVATION; SLEEP DISORDERED BREATHING; SUDDEN DEATH; SYMPATHETIC NERVE; ANIMAL; ARRHYTHMIAS, CARDIAC; COMPLICATION; PATHOPHYSIOLOGY; SUDDEN CARDIAC DEATH;

ANIMALS; ARRHYTHMIAS, CARDIAC; DEATH, SUDDEN, CARDIAC; HUMANS; SLEEP APNEA SYNDROMES;

EID: 84940776189     PISSN: 03636135     EISSN: 15221539     Source Type: Journal    
DOI: 10.1152/ajpheart.00285.2015     Document Type: Review

References (175)

1. Abe H, Takahashi M, Yaegashi H, Eda S, Tsunemoto H, Kamikozawa M, Koyama J, Yamazaki K, Ikeda U. Efficacy of continuous positive airway pressure on arrhythmias in obstructive sleep apnea patients. Heart Vessels 25: 63–69, 2010
2. Agnoletti G, Iserin L, Lafont A, Sidi D, Desnos M. Obstructive sleep apnoea and patent foramen ovale: successful treatment of symptoms by percutaneous foramen ovale closure. J Interv Cardiol 18: 393–395, 2005
3. Alonso-Fernandez A, de la Pena M, Romero D, Pierola J, Carrera M, Barcelo A, Soriano JB, Garcia Suquia A, Fernandez-Capitan C, Lorenzo A, Garcia-Rio F. Association between obstructive sleep apnea and pulmonary embolism. Mayo Clin Proc 88: 579–587, 2013
4. Arzt M, Luigart R, Schum C, Luthje L, Stein A, Koper I, Hecker C, Dumitrascu R, Schulz R. Sleep-disordered breathing in deep vein thrombosis and acute pulmonary embolism. Eur Respir J 40: 919–924, 2012
5. Arzt M, Young T, Finn L, Skatrud JB, Bradley TD. Association of sleep-disordered breathing and the occurrence of stroke. Am J Respir Crit Care Med 172: 1447–1451, 2005
6. Aurora RN, Chowdhuri S, Ramar K, Bista SR, Casey KR, Lamm CI, Kristo DA, Mallea JM, Rowley JA, Zak RS, Tracy SL. The treatment of central sleep apnea syndromes in adults: practice parameters with an evidence-based literature review and meta-analyses. Sleep 35: 17–40, 2012
7. Barbe F, Duran-Cantolla J, Sanchez-de-la-Torre M., Martinez- Alonso M., Carmona C., Barcelo A., Chiner E., Masa J.F, Gonzalez M, Marin JM, Garcia-Rio F, Diaz de Atauri J, Teran J, Mayos M, de la Pena M, Monasterio C, del Campo F, and Montserrat JM. Effect of continuous positive airway pressure on the incidence of hypertension and cardiovascular events in nonsleepy patients with obstructive sleep apnea: a randomized controlled trial. JAMA 307: 2161–2168, 2012
8. Barbe F, Mayoralas LR, Duran J, Masa JF, Maimo A, Montserrat JM, Monasterio C, Bosch M, Ladaria A, Rubio M, Rubio R, Medinas M, Hernandez L, Vidal S, Douglas NJ, Agusti AG. Treatment with continuous positive airway pressure is not effective in patients with sleep apnea but no daytime sleepiness. a randomized, controlled trial. Ann Intern Med 134: 1015–1023, 2001
9. Barcelo A, Pierola J, de la Pena M, Esquinas C, Sanchez-de la Torre M, Ayllon O, Alonso A, Agusti AG, Barbe F. Day-night variations in endothelial dysfunction markers and haemostatic factors in sleep apnoea. Eur Respir J 39: 913–918, 2012
10. Barcelo A, Pierola J, de la Pena M, Frontera G, Yanez A, Alonso- Fernandez A, Ayllon O, Agusti AG. Impaired circadian variation of platelet activity in patients with sleep apnea. Sleep Breath 16: 355–360, 2012
11. Bayir PT, Demirkan B, Bayir O, Duyuler S, Firat H, Guray U, Guray Y, Tatar EC. Impact of continuous positive airway pressure therapy on atrial electromechanical delay and P-wave dispersion in patients with obstructive sleep apnea. Ann Noninvasive Electrocardiol 19: 226–233, 2014
12. Bitter T, Nolker G, Vogt J, Prinz C, Horstkotte D, Oldenburg O. Predictors of recurrence in patients undergoing cryoballoon ablation for treatment of atrial fibrillation: the independent role of sleep-disordered breathing. J Cardiovasc Electrophysiol 23: 18–25, 2012
13. Braga B, Poyares D, Cintra F, Guilleminault C, Cirenza C, Horbach S, Macedo D, Silva R, Tufik S, De Paola AA. Sleep-disordered breathing and chronic atrial fibrillation. Sleep Med 10: 212–216, 2009
14. Brooks D, Horner RL, Kozar LF, Render-Teixeira CL, Phillipson EA. Obstructive sleep apnea as a cause of systemic hypertension. Evidence from a canine model. J Clin Invest 99: 106–109, 1997
15. Brostrom A, Sunnergren O, Johansson P, Svensson E, Ulander M, Nilsen P, Svanborg E. Symptom profile of undiagnosed obstructive sleep apnoea in hypertensive outpatients in primary care: a structural equation model analysis. Qual Prim Care 20: 287–298, 2012
16. Brugada P, Andries EW. Early postmyocardial infarction ventricular arrhythmias. Cardiovasc Clin 22: 165–180, 1992
17. Chen SM, Kuo CT, Lin KH, Chiang FT. Brugada syndrome without mutation of the cardiac sodium channel gene in a Taiwanese patient. J Formos Med Assoc 99: 860–862, 2000
18. Chou KT, Huang CC, Chen YM, Su KC, Shiao GM, Lee YC, Chan WL, Leu HB. Sleep apnea and risk of deep vein thrombosis: a nonrandomized, pair-matched cohort study. Am J Med 125: 374–380, 2012
19. Chung MK, Martin DO, Sprecher D, Wazni O, Kanderian A, Carnes CA, Bauer JA, Tchou PJ, Niebauer MJ, Natale A, Van Wagoner DR. C-reactive protein elevation in patients with atrial arrhythmias: inflammatory mechanisms and persistence of atrial fibrillation. Circulation 104: 2886–2891, 2001
20. Conen D, Chae CU, Glynn RJ, Tedrow UB, Everett BM, Buring JE, Albert CM. Risk of death and cardiovascular events in initially healthy women with new-onset atrial fibrillation. JAMA 305: 2080–2087, 2011
21. Craig S, Pepperell JC, Kohler M, Crosthwaite N, Davies RJ, Stradling JR. Continuous positive airway pressure treatment for obstructive sleep apnoea reduces resting heart rate but does not affect dysrhythmias: a randomised controlled trial. J Sleep Res 18: 329–336, 2009
22. Cushman M, Tsai AW, White RH, Heckbert SR, Rosamond WD, Enright P, Folsom AR. Deep vein thrombosis and pulmonary embolism in two cohorts: the longitudinal investigation of thromboembolism etiology. Am J Med 117: 19–25, 2004
23. Del Rio R, Moya EA, Parga MJ, Madrid C, Iturriaga R. Carotid body inflammation and cardiorespiratory alterations in intermittent hypoxia. Eur Respir J 39: 1492–1500, 2012
24. Drager LF, Pedrosa RP, Diniz PM, Diegues-Silva L, Marcondes B, Couto RB, Giorgi DM, Krieger EM, Lorenzi-Filho G. The effects of continuous positive airway pressure on prehypertension and masked hypertension in men with severe obstructive sleep apnea. Hypertension 57: 549–555, 2011
25. Endeshaw YW, White WB, Kutner M, Ouslander JG, Bliwise DL. Sleep-disordered breathing and 24-hour blood pressure pattern among older adults. J Gerontol A Biol Sci Med Sci 64: 280–285, 2009
26. Ferrier K, Campbell A, Yee B, Richards M, O’Meeghan T, Weatherall M, Neill A. Sleep-disordered breathing occurs frequently in stable outpatients with congestive heart failure. Chest 128: 2116–2122, 2005
27. Fletcher EC. Invited review: Physiological consequences of intermittent hypoxia: systemic blood pressure. J Appl Physiol (1985) 90: 1600–1605, 2001
28. Fletcher EC, Miller J, Schaaf JW, Fletcher JG. Urinary catecholamines before and after tracheostomy in patients with obstructive sleep apnea and hypertension. Sleep 10: 35–44, 1987
29. Franklin KA, Nilsson JB, Sahlin C, Naslund U. Sleep apnoea and nocturnal angina. Lancet 345: 1085–1087, 1995
30. Freet CS, Stoner JF, Tang X. Baroreflex and chemoreflex controls of sympathetic activity following intermittent hypoxia. Auton Neurosci 174: 8–14, 2013
31. Fung ML, Tipoe GL, Leung PS. Mechanisms of maladaptive responses of peripheral chemoreceptors to intermittent hypoxia in sleep-disordered breathing. Sheng Li Xue Bao 66: 23–29, 2014
32. Galatius-Jensen S, Hansen J, Rasmussen V, Bildsoe J, Therboe M, Rosenberg J. Nocturnal hypoxaemia after myocardial infarction: association with nocturnal myocardial ischaemia and arrhythmias. Br Heart J 72: 23–30, 1994
33. Gami AS. Systematic or opportunistic screening was more effective than usual care for detecting new cases of atrial fibrillation. Evid Based Med 13: 45, 2008
34. Gami AS, Hodge DO, Herges RM, Olson EJ, Nykodym J, Kara T, Somers VK. Obstructive sleep apnea, obesity, and the risk of incident atrial fibrillation. J Am Coll Cardiol 49: 565–571, 2007
35. Gami AS, Howard DE, Olson EJ, Somers VK. Day-night pattern of sudden death in obstructive sleep apnea. N Engl J Med 352: 1206–1214, 2005
36. Gami AS, Olson EJ, Shen WK, Wright RS, Ballman KV, Hodge DO, Herges RM, Howard DE, Somers VK. Obstructive sleep apnea and the risk of sudden cardiac death: a longitudinal study of 10,701 adults. J Am Coll Cardiol 62: 610–616, 2013
37. Gami AS, Pressman G, Caples SM, Kanagala R, Gard JJ, Davison DE, Malouf JF, Ammash NM, Friedman PA, Somers VK. Association of atrial fibrillation and obstructive sleep apnea. Circulation 110: 364–367, 2004
38. Garcia-Rio F, Alonso-Fernandez A, Armada E, Mediano O, Lores V, Rojo B, Fernandez-Lahera J, Fernandez-Navarro I, Carpio C, Ramirez T. CPAP effect on recurrent episodes in patients with sleep apnea and myocardial infarction. Int J Cardiol 168: 1328–1335, 2013
39. Garcia-Rio F, Racionero MA, Pino JM, Martinez I, Ortuno F, Villasante C, Villamor J. Sleep apnea and hypertension. Chest 117: 1417–1425, 2000
40. Gaw AC, Lee B, Gervacio-Domingo G, Antzelevitch C, Divinagracia R, Jocano F Jr. Unraveling the Enigma of Bangungut: Is Sudden Unexplained Nocturnal Death Syndrome (SUNDS) in the Philippines a Disease Allelic to the Brugada Syndrome? Philipp J Intern Med 49: 165–176, 2011
41. Genta-Pereira DC, Pedrosa RP, Lorenzi-Filho G, Drager LF. Sleep disturbances and resistant hypertension: association or causality? Curr Hypertens Rep 16: 459, 2014
42. Ghias M, Scherlag BJ, Lu Z, Niu G, Moers A, Jackman WM, Lazzara R, Po SS. The role of ganglionated plexi in apnea-related atrial fibrillation. J Am Coll Cardiol 54: 2075–2083, 2009
43. Gibson DN, Di Biase L, Mohanty P, Patel JD, Bai R, Sanchez J, Burkhardt JD, Heywood JT, Johnson AD, Rubenson DS, Horton R, Gallinghouse GJ, Beheiry S, Curtis GP, Cohen DN, Lee MY, Smith MR, Gopinath D, Lewis WR, Natale A. Stiff left atrial syndrome after catheter ablation for atrial fibrillation: clinical characterization, prevalence, and predictors. Heart Rhythm 8: 1364–1371, 2011
44. Gilman MP, Floras JS, Usui K, Kaneko Y, Leung RS, Bradley TD. Continuous positive airway pressure increases heart rate variability in heart failure patients with obstructive sleep apnoea. Clin Sci (Lond) 114: 243–249, 2008
45. Goodacre S. In the clinic. Deep venous thrombosis. Ann Intern Med 149: ITC3-1, 2008
46. Grimm W, Hildebrandt O, Nell C, Koehler U. Excessive daytime sleepiness and central sleep apnea in patients with stable heart failure. Int J Cardiol 176: 1447–1448, 2014
47. Grimm W, Koehler U. Cardiac arrhythmias and sleep-disordered breathing in patients with heart failure. Int J Mol Sci 15: 18693–18705, 2014
48. Guchlerner M, Kardos P, Liss-Koch E, Franke J, Wunderlich N, Bertog S, Sievert H. PFO and right-to-left shunting in patients with obstructive sleep apnea. J Clin Sleep Med 8: 375–380, 2012
49. Guilleminault C, Connolly SJ, Winkle RA. Cardiac arrhythmia and conduction disturbances during sleep in 400 patients with sleep apnea syndrome. Am J Cardiol 52: 490–494, 1983
50. Gupta S, Cepeda-Valery B, Romero-Corral A, Shamsuzzaman A, Somers VK, Pressman GS. Association between QRS duration and obstructive sleep apnea. J Clin Sleep Med 8: 649–654, 2012
51. Haas DC, Foster GL, Nieto FJ, Redline S, Resnick HE, Robbins JA, Young T, Pickering TG. Age-dependent associations between sleepdisordered breathing and hypertension: importance of discriminating between systolic/diastolic hypertension and isolated systolic hypertension in the Sleep Heart Health Study. Circulation 111: 614–621, 2005
52. Hall AB, Ziadi MC, Leech JA, Chen SY, Burwash IG, Renaud J, deKemp RA, Haddad H, Mielniczuk LM, Yoshinaga K, Guo A, Chen L, Walter O, Garrard L, DaSilva JN, Floras JS, Beanlands RS. Effects of short-term continuous positive airway pressure on myocardial sympathetic nerve function and energetics in patients with heart failure and obstructive sleep apnea: a randomized study. Circulation 130: 892–901, 2014
53. Hara H, Virmani R, Ladich E, Mackey-Bojack S, Titus J, Reisman M, Gray W, Nakamura M, Mooney M, Poulose A, Schwartz RS. Patent foramen ovale: current pathology, pathophysiology, and clinical status. J Am Coll Cardiol 46: 1768–1776, 2005
54. Hsieh SW, Lai CL, Liu CK, Hsieh CF, Hsu CY. Obstructive sleep apnea linked to wake-up strokes. J Neurol 259: 1433–1439, 2012
55. Iftikhar IH, Valentine CW, Bittencourt LR, Cohen DL, Fedson AC, Gislason T, Penzel T, Phillips CL, Yu-sheng L, Pack AI, Magalang UJ. Effects of continuous positive airway pressure on blood pressure in patients with resistant hypertension and obstructive sleep apnea: a metaanalysis. J Hypertens 32: 2341–2350, 2014
56. Imadojemu VA, Mawji Z, Kunselman A, Gray KS, Hogeman CS, Leuenberger UA. Sympathetic chemoreflex responses in obstructive sleep apnea and effects of continuous positive airway pressure therapy. Chest 131: 1406–1413, 2007
57. Ishikawa J, Hoshide S, Eguchi K, Ishikawa S, Pickering TG, Shimada K, Kario K. Increased low-grade inflammation and plasminogenactivator inhibitor-1 level in nondippers with sleep apnea syndrome. J Hypertens 26: 1181–1187, 2008
58. Islam S, Taylor CJ, Ormiston IW. Effects of maxillomandibular advancement on systemic blood pressure in patients with obstructive sleep apnoea. Br J Oral Maxillofac Surg 53: 34–38, 2015
59. Iturriaga R, Moya EA, Del Rio R. Cardiorespiratory alterations induced by intermittent hypoxia in a rat model of sleep apnea. Adv Exp Med Biol 669: 271–274, 2010
60. Iturriaga R, Rey S, Del Rio R. Cardiovascular and ventilatory acclimatization induced by chronic intermittent hypoxia: a role for the carotid body in the pathophysiology of sleep apnea. Biol Res 38: 335–340, 2005
61. Javaheri S, Corbett WS. Association of low PaCO2 with central sleep apnea and ventricular arrhythmias in ambulatory patients with stable heart failure. Ann Intern Med 128: 204–207, 1998
62. Javaheri S, Javaheri A. Sleep apnea, heart failure, and pulmonary hypertension. Curr Heart Fail Rep 10: 315–320, 2013
63. Javaheri S, Parker TJ, Liming JD, Corbett WS, Nishiyama H, Wexler L, Roselle GA. Sleep apnea in 81 ambulatory male patients with stable heart failure. Types and their prevalences, consequences, and presentations. Circulation 97: 2154–2159, 1998
64. Jiang X, Yongxiang W, Wei Z, Xiangfeng Z, Jie L, Achakzai R, Shuang L. Higher dose of warfarin for patients with pulmonary embolism complicated by obstructive sleep apnea hypopnea syndrome. Heart Lung 43: 358–362, 2014
65. Kanagala R, Murali NS, Friedman PA, Ammash NM, Gersh BJ, Ballman KV, Shamsuzzaman AS, Somers VK. Obstructive sleep apnea and the recurrence of atrial fibrillation. Circulation 107: 2589– 2594, 2003
66. Kar S. Cardiovascular implications of obstructive sleep apnea associated with the presence of a patent foramen ovale. Sleep Med Rev 18: 399–404, 2014
67. Kara T, Narkiewicz K, Somers VK. Chemoreflexes–physiology and clinical implications. Acta Physiol Scand 177: 377–384, 2003
68. Kasiakogias ATC, Thomopoulos C, Andrikou I, Aragiannis D, Dimitriadis K, Tsiachris D, Bilo G, Sideris S, Filis K, Parati G, Stefanadis C. Evening versus morning dosing of antihypertensive drugs in hypertensive patients with sleep apnoea: a cross-over study. J Hypertens 33: 393–400, 2015
69. Kendzerska T, Gershon AS, Hawker G, Leung RS, Tomlinson G. Obstructive sleep apnea and risk of cardiovascular events and all-cause mortality: a decade-long historical cohort study. PLoS Med 11: e1001599, 2014
70. Konecny T, Khanna AD, Novak J, Jama AA, Zawadowski GM, Orban M, Pressman G, Bukartyk J, Kara T, Cetta F Jr, Borlaug BA, Somers VK, Reeder GS. Interatrial pressure gradients during simulated obstructive sleep apnea: a catheter-based study. Catheter Cardiovasc Interv 84: 1138–1145, 2014
71. Krawczyk M, Flinta I, Garncarek M, Jankowska EA, Banasiak W, Germany R, Javaheri S, Ponikowski P. Sleep disordered breathing in patients with heart failure. Cardiol J 20: 345–355, 2013
72. Kuniyoshi FH, Garcia-Touchard A, Gami AS, Romero-Corral A, van der Walt C, Pusalavidyasagar S, Kara T, Caples SM, Pressman GS, Vasquez EC, Lopez-Jimenez F, Somers VK. Day-night variation of acute myocardial infarction in obstructive sleep apnea. J Am Coll Cardiol 52: 343–346, 2008
73. Lamberts M, Nielsen OW, Lip GY, Ruwald MH, Christiansen CB, Kristensen SL, Torp-Pedersen C, Hansen ML, Gislason GH. Cardiovascular risk in patients with sleep apnoea with or without continuous positive airway pressure therapy: follow-up of 4.5 million Danish adults. J Intern Med 276: 659–666, 2014
74. Lamy C, Giannesini C, Zuber M, Arquizan C, Meder JF, Trystram D, Coste J, Mas JL. Clinical and imaging findings in cryptogenic stroke patients with and without patent foramen ovale: the PFO-ASA Study. Atrial Septal Aneurysm. Stroke 33: 706–711, 2002
75. Lanfranchi PA, Somers VK. Sleep-disordered breathing in heart failure: characteristics and implications. Respir Physiol Neurobiol 136: 153–165, 2003
76. Lee S, Thomas RJ, Kim H, Seo HS, Baik I, Yoon DW, Kim SJ, Lee SK, Shin C. Association between high nocturnal blood pressure and white matter change and its interaction by obstructive sleep apnoea among normotensive adults. J Hypertens 32: 2005–2012, 2014
77. Lesske J, Fletcher EC, Bao G, Unger T. Hypertension caused by chronic intermittent hypoxia–influence of chemoreceptors and sympathetic nervous system. J Hypertens 15: 1593–1603, 1997
78. Leuenberger UA, Brubaker D, Quraishi S, Hogeman CS, Imadojemu VA, Gray KS. Effects of intermittent hypoxia on sympathetic activity and blood pressure in humans. Auton Neurosci 121: 87–93, 2005
79. Levy P, Ryan S, Oldenburg O, Parati G. Sleep apnoea and the heart. Eur Respir Rev 22: 333–352, 2013
80. Liu M, Yang KC, Dudley SC Jr. Cardiac sodium channel mutations: why so many phenotypes? Nat Rev Cardiol 11: 607–615, 2014
81. Luu M, Stevenson WG, Stevenson LW, Baron K, Walden J. Diverse mechanisms of unexpected cardiac arrest in advanced heart failure. Circulation 80: 1675–1680, 1989
82. Macedo PG, Brugada J, Leinveber P, Benito B, Molina I, Sert- Kuniyoshi F, Adachi T, Bukartyk J, van der Walt C, Konecny T, Maharaj S, Kara T, Montserrat J, Somers V. Sleep-disordered breathing in patients with the Brugada syndrome. Am J Cardiol 107: 709–713, 2011
83. Mansfield D, Kaye DM, Brunner La Rocca H, Solin P, Esler MD, Naughton MT. Raised sympathetic nerve activity in heart failure and central sleep apnea is due to heart failure severity. Circulation 107: 1396–1400, 2003
84. Mansukhani MP, Allison TG, Lopez-Jimenez F, Somers VK, Caples SM. Functional aerobic capacity in patients with sleep-disordered breathing. Am J Cardiol 111: 1650–1654, 2013
85. Mansukhani MP, Bellolio MF, Kolla BP, Enduri S, Somers VK, Stead LG. Worse outcome after stroke in patients with obstructive sleep apnea: an observational cohort study. J Stroke Cerebrovasc Dis 20: 401–405, 2011
86. Mansukhani MP, Calvin AD, Kolla BP, Brown RD Jr, Lipford MC, Somers VK, Caples SM. The association between atrial fibrillation and stroke in patients with obstructive sleep apnea: a population-based case-control study. Sleep Med 14: 243–246, 2013
87. Mansukhani MP, Kara T, Caples SM, Somers VK. Chemoreflexes, sleep apnea, and sympathetic dysregulation. Curr Hypertens Rep 16: 476, 2014
88. Mansukhani MP, Wang S, Somers VK. Chemoreflex physiology and implications for sleep apnoea: implications from studies in humans. Exp Physiol 100: 130–135, 2014
89. Marin JM, Agusti A, Villar I, Forner M, Nieto D, Carrizo SJ, Barbe F, Vicente E, Wei Y, Nieto FJ, Jelic S. Association between treated and untreated obstructive sleep apnea and risk of hypertension. JAMA 307: 2169–2176, 2012
90. Marin JM, Carrizo SJ, Vicente E, Agusti AG. Long-term cardiovascular outcomes in men with obstructive sleep apnoea-hypopnoea with or without treatment with continuous positive airway pressure: an observational study. Lancet 365: 1046–1053, 2005
91. Martinez-Garcia MA, Capote F, Campos-Rodriguez F, Lloberes P, Diaz de Atauri MJ, Somoza M, Masa JF, Gonzalez M, Sacristan L, Barbe F, Duran-Cantolla J, Aizpuru F, Manas E, Barreiro B, Mosteiro M, Cebrian JJ, de la Pena M, Garcia-Rio F, Maimo A, Zapater J, Hernandez C, Grau SanMarti N, Montserrat JM. Effect of CPAP on blood pressure in patients with obstructive sleep apnea and resistant hypertension: the HIPARCO randomized clinical trial. JAMA 310: 2407–2415, 2013
92. Matsuo K, Kurita T, Inagaki M, Kakishita M, Aihara N, Shimizu W, Taguchi A, Suyama K, Kamakura S, Shimomura K. The circadian pattern of the development of ventricular fibrillation in patients with Brugada syndrome. Eur Heart J 20: 465–470, 1999
93. Mehra R, Benjamin EJ, Shahar E, Gottlieb DJ, Nawabit R, Kirchner HL, Sahadevan J, Redline S. Association of nocturnal arrhythmias with sleep-disordered breathing: The Sleep Heart Health Study. Am J Respir Crit Care Med 173: 910–916, 2006
94. Mehra R, Stone KL, Varosy PD, Hoffman AR, Marcus GM, Blackwell T, Ibrahim OA, Salem R, Redline S. Nocturnal arrhythmias across a spectrum of obstructive and central sleep-disordered breathing in older men: outcomes of sleep disorders in older men (MrOS sleep) study. Arch Intern Med 169: 1147–1155, 2009
95. Meissner I, Whisnant JP, Khandheria BK, Spittell PC, O’Fallon WM, Pascoe RD, Enriquez-Sarano M, Seward JB, Covalt JL, Sicks JD, Wiebers DO. Prevalence of potential risk factors for stroke assessed by transesophageal echocardiography and carotid ultrasonography: the SPARC study. Stroke Prevention: Assessment of Risk in a Community. Mayo Clin Proc 74: 862–869, 1999
96. Melles RB, Katz B. Sudden, unexplained nocturnal death syndrome and night terrors. JAMA 257: 2918–2919, 1987
97. Mokhlesi B, Finn LA, Hagen EW, Young T, Hla KM, Van Cauter E, Peppard PE. Obstructive sleep apnea during REM sleep and hypertension. Results of the Wisconsin Sleep Cohort. Am J Respir Crit Care Med 190: 1158–1167, 2014
98. Monahan K, Brewster J, Wang L, Parvez B, Goyal S, Roden DM, Darbar D. Relation of the severity of obstructive sleep apnea in response to anti-arrhythmic drugs in patients with atrial fibrillation or atrial flutter. Am J Cardiol 110: 369–372, 2012
99. Monahan K, Storfer-Isser A, Mehra R, Shahar E, Mittleman M, Rottman J, Punjabi N, Sanders M, Quan SF, Resnick H, Redline S. Triggering of nocturnal arrhythmias by sleep-disordered breathing events. J Am Coll Cardiol 54: 1797–1804, 2009
100. Mooe T, Franklin KA, Wiklund U, Rabben T, Holmstrom K. Sleepdisordered breathing and myocardial ischemia in patients with coronary artery disease. Chest 117: 1597–1602, 2000
101. Morgenthaler T, Kapen S, Lee Chiong T, Alessi C, Boehlecke B, Brown T, Coleman J, Friedman L, Kapur V, Owens J, Pancer J, Swick T. Practice parameters for the medical therapy of obstructive sleep apnea. Sleep 29: 1031–1035, 2006
102. Motoda C, Nakano Y, Oda N, Suenari K, Makita Y, Sairaku A, Kajihara K, Tokuyama T, Fujiwara M, Kihara Y. Sleep-disordered breathing predicts sinus node dysfunction in persistent atrial fibrillation patients undergoing pulmonary vein isolation. J Cardiol 60: 321–326, 2012
103. Munoz R, Duran-Cantolla J, Martinez-Vila E. Obstructive sleep apnea-hypopnea and incident stroke: the sleep heart health study. Am J Respir Crit Care Med 182: 1332, 2010
104. Myhill PC, Davis WA, Peters KE, Chubb SA, Hillman D, Davis TM. Effect of continuous positive airway pressure therapy on cardiovascular risk factors in patients with type 2 diabetes and obstructive sleep apnea. J Clin Endocrinol Metab 97: 4212–4218, 2012
105. Narkiewicz K, Kato M, Phillips BG, Pesek CA, Davison DE, Somers VK. Nocturnal continuous positive airway pressure decreases daytime sympathetic traffic in obstructive sleep apnea. Circulation 100: 2332–2335, 1999
106. Narkiewicz K, van de Borne PJ, Cooley RL, Dyken ME, Somers VK. Sympathetic activity in obese subjects with and without obstructive sleep apnea. Circulation 98: 772–776, 1998
107. Narkiewicz K, van de Borne PJ, Montano N, Dyken ME, Phillips BG, Somers VK. Contribution of tonic chemoreflex activation to sympathetic activity and blood pressure in patients with obstructive sleep apnea. Circulation 97: 943–945, 1998
108. Narkiewicz K, van de Borne PJ, Pesek CA, Dyken ME, Montano N, Somers VK. Selective potentiation of peripheral chemoreflex sensitivity in obstructive sleep apnea. Circulation 99: 1183–1189, 1999
109. Ng CY, Liu T, Shehata M, Stevens S, Chugh SS, Wang X. Metaanalysis of obstructive sleep apnea as predictor of atrial fibrillation recurrence after catheter ablation. Am J Cardiol 108: 47–51, 2011
110. Nisar SA, Muppidi R, Duggal S, Hernandez AV, Kalahasti V, Jaber W, Minai OA. Impaired functional capacity predicts mortality in patients with obstructive sleep apnea. Ann Am Thorac Soc 11: 1056–1063, 2014
111. O’Donnell CP, Ayuse T, King ED, Schwartz AR, Smith PL, Robotham JL. Airway obstruction during sleep increases blood pressure without arousal. J Appl Physiol (1985) 80: 773–781, 1996
112. Otto ME, Belohlavek M, Romero-Corral A, Gami AS, Gilman G, Svatikova A, Amin RS, Lopez-Jimenez F, Khandheria BK, Somers VK. Comparison of cardiac structural and functional changes in obese otherwise healthy adults with versus without obstructive sleep apnea. Am J Cardiol 99: 1298–1302, 2007
113. Pedrosa RP, Drager LF, Gonzaga CC, Sousa MG, de Paula LK, Amaro AC, Amodeo C, Bortolotto LA, Krieger EM, Bradley TD, Lorenzi-Filho G. Obstructive sleep apnea: the most common secondary cause of hypertension associated with resistant hypertension. Hypertension 58: 811–817, 2011
114. Peng YH, Liao WC, Chung WS, Muo CH, Chu CC, Liu CJ, Kao CH. Association between obstructive sleep apnea and deep vein thrombosis / pulmonary embolism: a population-based retrospective cohort study. Thromb Res 134: 340–345, 2014
115. Peppard PE, Young T, Palta M, Skatrud J. Prospective study of the association between sleep-disordered breathing and hypertension. N Engl J Med 342: 1378–1384, 2000
116. Pepperell JC, Ramdassingh-Dow S, Crosthwaite N, Mullins R, Jenkinson C, Stradling JR, Davies RJ. Ambulatory blood pressure after therapeutic and subtherapeutic nasal continuous positive airway pressure for obstructive sleep apnoea: a randomised parallel trial. Lancet 359: 204–210, 2002
117. Phillips CL, Grunstein RR, Darendeliler MA, Mihailidou AS, Srinivasan VK, Yee BJ, Marks GB, Cistulli PA. Health outcomes of continuous positive airway pressure versus oral appliance treatment for obstructive sleep apnea: a randomized controlled trial. Am J Respir Crit Care Med 187: 879–887, 2013
118. Phillipson EA, McClean PA, Sullivan CE, Zamel N. Interaction of metabolic and behavioral respiratory control during hypercapnia and speech. Am Rev Respir Dis 117: 903–909, 1978
119. Pinet C, Orehek J. CPAP suppression of awake right-to-left shunting through patent foramen ovale in a patient with obstructive sleep apnoea. Thorax 60: 880–881, 2005
120. Pinto P, Barbara C, Montserrat JM, Patarrao RS, Guarino MP, Carmo MM, Macedo MP, Martinho C, Dias R, Gomes MJ. Effects of CPAP on nitrate and norepinephrine levels in severe and mild-moderate sleep apnea. BMC Pulm Med 13: 13, 2013
121. Portaluppi F, Provini F, Cortelli P, Plazzi G, Bertozzi N, Manfredini R, Fersini C, Lugaresi E. Undiagnosed sleep-disordered breathing among male nondippers with essential hypertension. J Hypertens 15: 1227–1233, 1997
122. Raghuram A, Clay R, Kumbam A, Tereshchenko LG, Khan A. A systematic review of the association between obstructive sleep apnea and ventricular arrhythmias. J Clin Sleep Med 10: 1155–1160, 2014
123. Redline S, Yenokyan G, Gottlieb DJ, Shahar E, O’Connor GT, Resnick HE, Diener-West M, Sanders MH, Wolf PA, Geraghty EM, Ali T, Lebowitz M, Punjabi NM. Obstructive sleep apnea-hypopnea and incident stroke: the sleep heart health study. Am J Respir Crit Care Med 182: 269–277, 2010
124. Redolfi S, Arnulf I, Pottier M, Lajou J, Koskas I, Bradley TD, Similowski T. Attenuation of obstructive sleep apnea by compression stockings in subjects with venous insufficiency. Am J Respir Crit Care Med 184: 1062–1066, 2011
125. Reggiani M, Karttunen V, Wartiovaara-Kautto U, Riutta A, Uchiyama S, Hillbom M. Fibrinolytic activity and platelet function in subjects with obstructive sleep apnoea and a patent foramen ovale: is there an option for prevention of ischaemic stroke? Stroke Res Treat 2012: 945849, 2012
126. ResMed. SERVE-HF [Online]. http://www.resmed.com/us/en/serve-hf.html, 2015
127. Ringler J, Basner RC, Shannon R, Schwartzstein R, Manning H, Weinberger SE, Weiss JW. Hypoxemia alone does not explain blood pressure elevations after obstructive apneas. J Appl Physiol (1985) 69: 2143–2148, 1990
128. Rizzi CF, Cintra F, Mello-Fujita L, Rios LF, Mendonca ET, Feres MC, Tufik S, Poyares D. Does obstructive sleep apnea impair the cardiopulmonary response to exercise? Sleep 36: 547–553, 2013
129. Robinson GV, Smith DM, Langford BA, Davies RJ, Stradling JR. Continuous positive airway pressure does not reduce blood pressure in nonsleepy hypertensive OSA patients. Eur Respir J 27: 1229–1235, 2006
130. Rossi VA, Stoewhas AC, Camen G, Steffel J, Bloch KE, Stradling JR, Kohler M. The effects of continuous positive airway pressure therapy withdrawal on cardiac repolarization: data from a randomized controlled trial. Eur Heart J 33: 2206–2212, 2012
131. Rupprecht S, Hutschenreuther J, Brehm B, Figulla HR, Witte OW, Schwab M. Causality in the relationship between central sleep apnea and paroxysmal atrial fibrillation. Sleep Med 9: 462–464, 2008
132. Ryan CM, Usui K, Floras JS, Bradley TD. Effect of continuous positive airway pressure on ventricular ectopy in heart failure patients with obstructive sleep apnoea. Thorax 60: 781–785, 2005
133. Sano K, Watanabe E, Hayano J, Mieno Y, Sobue Y, Yamamoto M, Ichikawa T, Sakakibara H, Imaizumi K, Ozaki Y. Central sleep apnoea and inflammation are independently associated with arrhythmia in patients with heart failure. Eur J Heart Fail 15: 1003–1010, 2013
134. Sasaki N, Ozono R, Yamauchi R, Teramen K, Munemori M, Hamada H, Edahiro Y, Ishii K, Seto A, Kihara Y. Age-related differences in the mechanism of nondipping among patients with obstructive sleep apnea syndrome. Clin Exp Hypertens 34: 270–277, 2012
135. Schultz HD, Marcus NJ, Del Rio R. Role of the carotid body in the pathophysiology of heart failure. Curr Hypertens Rep 15: 356–362, 2013
136. Shah RV, Abbasi SA, Heydari B, Farhad H, Dodson JA, Bakker JP, John RM, Veves A, Malhotra A, Blankstein R, Jerosch-Herold M, Kwong RY, Neilan TG. Obesity and sleep apnea are independently associated with adverse left ventricular remodeling and clinical outcome in patients with atrial fibrillation and preserved ventricular function. Am Heart J 167: 620–626, 2014
137. Shaikh ZF, Jaye J, Ward N, Malhotra A, de Villa M, Polkey MI, Mullen MJ, Morrell MJ. Patent foramen ovale in severe obstructive sleep apnea: clinical features and effects of closure. Chest 143: 56–63, 2013
138. Shamsuzzaman A, Amin RS, Calvin AD, Davison D, Somers VK. Severity of obstructive sleep apnea is associated with elevated plasma fibrinogen in otherwise healthy patients. Sleep Breath 18: 761–766, 2014
139. Shamsuzzaman AS, Winnicki M, Lanfranchi P, Wolk R, Kara T, Accurso V, Somers VK. Elevated C-reactive protein in patients with obstructive sleep apnea. Circulation 105: 2462–2464, 2002
140. Shiomi T, Guilleminault C, Stoohs R, Schnittger I. Leftward shift of the interventricular septum and pulsus paradoxus in obstructive sleep apnea syndrome. Chest 100: 894–902, 1991
141. Sin DD, Fitzgerald F, Parker JD, Newton G, Floras JS, Bradley TD. Risk factors for central and obstructive sleep apnea in 450 men and women with congestive heart failure. Am J Respir Crit Care Med 160: 1101–1106, 1999
142. Smith ML, Niedermaier ON, Hardy SM, Decker MJ, Strohl KP. Role of hypoxemia in sleep apnea-induced sympathoexcitation. J Auton Nerv Syst 56: 184–190, 1996
143. Solin P, Kaye DM, Little PJ, Bergin P, Richardson M, Naughton MT. Impact of sleep apnea on sympathetic nervous system activity in heart failure. Chest 123: 1119–1126, 2003
144. Somers VK, Dyken ME, Clary MP, Abboud FM. Sympathetic neural mechanisms in obstructive sleep apnea. J Clin Invest 96: 1897–1904, 1995
145. Somers VK, Dyken ME, Mark AL, Abboud FM. Sympathetic-nerve activity during sleep in normal subjects. N Engl J Med 328: 303–307, 1993
146. Somers VK, Mark AL, Abboud FM. Potentiation of sympathetic nerve responses to hypoxia in borderline hypertensive subjects. Hypertension 11: 608–612, 1988
147. Somers VK, Mark AL, Zavala DC, Abboud FM. Contrasting effects of hypoxia and hypercapnia on ventilation and sympathetic activity in humans. J Appl Physiol (1985) 67: 2101–2106, 1989
148. Somers VK, Mark AL, Zavala DC, Abboud FM. Influence of ventilation and hypocapnia on sympathetic nerve responses to hypoxia in normal humans. J Appl Physiol (1985) 67: 2095–2100, 1989
149. Somers VK, White DP, Amin R, Abraham WT, Costa F, Culebras A, Daniels S, Floras JS, Hunt CE, Olson LJ, Pickering TG, Russell R, Woo M, Young T. Sleep apnea and cardiovascular disease: an American Heart Association/American College of Cardiology Foundation Scientific Statement from the American Heart Association Council for High Blood Pressure Research Professional Education Committee, Council on Clinical Cardiology, Stroke Council, and Council on Cardiovascular Nursing. J Am Coll Cardiol 52: 686–717, 2008
150. Sun H, Shi J, Li M, Chen X. Impact of continuous positive airway pressure treatment on left ventricular ejection fraction in patients with obstructive sleep apnea: a meta-analysis of randomized controlled trials. PLoS One 8: e62298, 2013
151. Takasugi N, Nishigaki K, Kubota T, Tsuchiya K, Natsuyama K, Takasugi M, Nawa T, Ojio S, Aoyama T, Kawasaki M, Takemura G, Minatoguchi S. Sleep apnoea induces cardiac electrical instability assessed by T-wave alternans in patients with congestive heart failure. Eur J Heart Fail 11: 1063–1070, 2009
152. Tkacova R, McNicholas WT, Javorsky M, Fietze I, Sliwinski P, Parati G, Grote L, Hedner J. Nocturnal intermittent hypoxia predicts prevalent hypertension in the European Sleep Apnoea Database cohort study. Eur Respir J 44: 931–941, 2014
153. Tobaldini E, Brugada J, Benito B, Molina I, Montserrat J, Kara T, Leinveber P, Porta A, Macedo PG, Montano N, Somers VK. Cardiac autonomic control in Brugada syndrome patients during sleep: the effects of sleep disordered breathing. Int J Cardiol 168: 3267–3272, 2013
154. Trinder J, Merson R, Rosenberg JI, Fitzgerald F, Kleiman J, Douglas Bradley T. Pathophysiological interactions of ventilation, arousals, and blood pressure oscillations during cheyne-stokes respiration in patients with heart failure. Am J Respir Crit Care Med 162: 808–813, 2000
155. Trombetta IC, Maki-Nunes C, Toschi-Dias E, Alves MJ, Rondon MU, Cepeda FX, Drager LF, Braga AM, Lorenzi-Filho G, Negrao CE. Obstructive sleep apnea is associated with increased chemoreflex sensitivity in patients with metabolic syndrome. Sleep 36: 41–49, 2013
156. Tungsanga K, Sriboonlue P. Sudden unexplained death syndrome in north-east Thailand. Int J Epidemiol 22: 81–87, 1993
157. Ueno LM, Drager LF, Rodrigues AC, Rondon MU, Braga AM, Mathias W Jr, Krieger EM, Barretto AC, Middlekauff HR, Lorenzi- Filho G, Negrao CE. Effects of exercise training in patients with chronic heart failure and sleep apnea. Sleep 32: 637–647, 2009
158. Urbano F, Roux F, Schindler J, Mohsenin V. Impaired cerebral autoregulation in obstructive sleep apnea. J Appl Physiol (1985) 105: 1852–1857, 2008
159. Valham F, Mooe T, Rabben T, Stenlund H, Wiklund U, Franklin KA. Increased risk of stroke in patients with coronary artery disease and sleep apnea: a 10-year follow-up. Circulation 118: 955–960, 2008
160. van de Borne P, Oren R, Abouassaly C, Anderson E, Somers VK. Effect of Cheyne-Stokes respiration on muscle sympathetic nerve activity in severe congestive heart failure secondary to ischemic or idiopathic dilated cardiomyopathy. Am J Cardiol 81: 432–436, 1998
161. Varounis C, Katsi V, Kallikazaros IE, Tousoulis D, Stefanadis C, Parissis J, Lekakis J, Siristatidis C, Manolis AJ, Makris T. Effect of CPAP on blood pressure in patients with obstructive sleep apnea and resistant hypertension: a systematic review and meta-analysis. Int J Cardiol 175: 195–198, 2014
162. Vatta M, Dumaine R, Varghese G, Richard TA, Shimizu W, Aihara N, Nademanee K, Brugada R, Brugada J, Veerakul G, Li H, Bowles NE, Brugada P, Antzelevitch C, Towbin JA. Genetic and biophysical basis of sudden unexplained nocturnal death syndrome (SUNDS), a disease allelic to Brugada syndrome. Hum Mol Genet 11: 337–345, 2002
163. Waeber B, Burnier M. Ambulatory blood pressure monitoring to assess cardiovascular risk in women. Hypertension 57: 377–378, 2011
164. White JM, Veale AG, Ruygrok PN. Patent foramen ovale closure in the treatment of obstructive sleep apnea. J Invasive Cardiol 25: E169–171, 2013
165. Wouters A, Lemmens R, Dupont P, Thijs V. Wake-up stroke and stroke of unknown onset: a critical review. Front Neurol 5: 153, 2014
166. Wu LA, Malouf JF, Dearani JA, Hagler DJ, Reeder GS, Petty GW, Khandheria BK. Patent foramen ovale in cryptogenic stroke: current understanding and management options. Arch Intern Med 164: 950–956, 2004
167. Wu XL, Yu X, Yao L, Mokhlesi B, Wei Y. Treatment of obstructive sleep apnea reduces the risk of repeat revascularization after percutaneous coronary intervention. Chest 147: 708–718, 2014
168. Yaggi HK, Concato J, Kernan WN, Lichtman JH, Brass LM, Mohsenin V. Obstructive sleep apnea as a risk factor for stroke and death. N Engl J Med 353: 2034–2041, 2005
169. Yorgun H, Kabakci G, Canpolat U, Kirmizigul E, Sahiner L, Ates AH, Sendur MA, Kaya EB, Demir AU, Aytemir K, Tokgozoglu L, Oto A. Predictors of blood pressure reduction with nocturnal continuous positive airway pressure therapy in patients with obstructive sleep apnea and prehypertension. Angiology 65: 98–103, 2014
170. Young T, Peppard P, Palta M, Hla KM, Finn L, Morgan B, Skatrud J. Population-based study of sleep-disordered breathing as a risk factor for hypertension. Arch Intern Med 157: 1746–1752, 1997
171. Yumino D, Wang H, Floras JS, Newton GE, Mak S, Ruttanaumpawan P, Parker JD, Bradley TD. Prevalence and physiological predictors of sleep apnea in patients with heart failure and systolic dysfunction. J Card Fail 15: 279–285, 2009
172. Zeidan-Shwiri T, Aronson D, Atalla K, Blich M, Suleiman M, Marai I, Gepstein L, Lavie L, Lavie P, Boulos M. Circadian pattern of life-threatening ventricular arrhythmia in patients with sleep-disordered breathing and implantable cardioverter-defibrillators. Heart Rhythm 8: 657–662, 2011
173. Zhang M, Li L, Fowler D, Zhao Z, Wei D, Zhang Y, Burke A. Causes of sudden death in patients with obstructive sleep apnea. J Forensic Sci 58: 1171–1174, 2013
174. Zhao J, Xu W, Yun F, Zhao H, Li W, Gong Y, Yuan Y, Yan S, Zhang S, Ding X, Wang D, Zhang C, Dong D, Xiu C, Yang N, Liu L, Xue J, Li Y. Chronic obstructive sleep apnea causes atrial remodeling in canines: mechanisms and implications. Basic Res Cardiol 109: 427, 2014
175. Zoccal DB, Machado BH. Coupling between respiratory and sympathetic activities as a novel mechanism underpinning neurogenic hypertension. Curr Hypertens Rep 13: 229–236, 2011.